
New Delhi [India]: India has expanded its COVID-19 vaccination drive with the inclusion of children in the age group of 12-14 years starting on Wednesday while those aged above 60 years are also eligible now for the precaution dose.
The children in the said age group will be administered Corbevax vaccine manufactured by Hyderabad-based Biological E. It is India's first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine against COVID-19.